US Broker Ratings

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Significant Upside Potential with 65% Growth Projection

Catalyst Pharmaceuticals, Inc. (CPRX), a key player in the biotechnology sector, has been making waves with its impressive performance metrics and growth potential. Based in Coral Gables, Florida, this commercial-stage..

Mesoblast Limited (MESO) Stock Analysis: Exploring a Potential 55.89% Upside

Mesoblast Limited (NASDAQ: MESO), an Australian biotechnology innovator, is capturing investor interest with its ambitious strides in regenerative medicine. Specializing in mesenchymal lineage cells, Mesoblast is at the forefront of..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Navigating a 20% Potential Upside in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention with its 20% potential upside, as suggested by current analyst ratings. As a prominent player in the biotechnology sector, Scholar..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Deep Dive into Its 11.58% Upside Potential

Alignment Healthcare, Inc. (ALHC), a promising player in the healthcare plans industry, is garnering significant attention from investors due to its potential for growth and its consumer-centric approach to healthcare...

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 4.17% Potential Upside Amidst Strong Revenue Growth

Warby Parker Inc. (WRBY), a dominant player in the eyewear industry, has caught the attention of investors with its solid revenue growth and a promising average target price suggesting a..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: A 36.3% Revenue Growth Drives Investor Interest

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, continues to intrigue investors with its innovative approach and significant revenue growth. Headquartered in Seattle, Washington, this commercial-stage..

MannKind Corporation (MNKD) Stock Analysis: A Biotech Gem with 86.77% Potential Upside

MannKind Corporation (NASDAQ: MNKD) has been finding its stride within the biotechnology sector, offering promising opportunities for investors seeking exposure to the healthcare industry. With a market capitalization of $1.74..

Artivion, Inc. (AORT) Stock Analysis: Healthcare Innovator with a 9.31% Upside Potential

Artivion, Inc. (AORT), a key player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its robust portfolio of innovative products and promising market..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Gem with a 22.4% Revenue Growth

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is a compelling name in the biotechnology sector that has been gaining traction among investors, particularly due to its focus on autoimmune diseases—a field characterized..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 20.70% Potential Upside for Investors

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, has positioned itself as a prominent provider of pharmacy services to long-term care facilities (LTCFs) across the..

Certara, Inc. (CERT) Stock Analysis: Healthcare Innovator with a 7.81% Potential Upside

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, operates within the health information services industry. With a current market capitalization of $2.16 billion, Certara is a formidable..

Merus N.V. (MRUS) Investor Outlook: Analyzing a 20.40% Revenue Growth in the Booming Biotech Sector

Merus N.V. (NASDAQ: MRUS), a clinical-stage immuno-oncology company based in the Netherlands, has been making waves in the biotechnology industry. With a market capitalization of $7.14 billion, Merus focuses on..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Potential 135% Upside in Biotech

Apogee Therapeutics, Inc. (NASDAQ: APGE) is making waves in the biotechnology sector with its cutting-edge approach to treating inflammatory and immunological diseases. As a clinical-stage company, Apogee is drawing attention..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Promising 40.81% Upside in the Healthcare Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) has captured the attention of investors with its innovative approach to spinal disorder treatments and promising financial outlook. With a market capitalization of $2.01 billion,..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 66% Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB) presents an intriguing opportunity for investors within the healthcare sector, particularly those focused on biotechnology. As a prominent player in the Chinese market, Zai Lab..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 58.70% Potential Upside in the Medical Devices Sector

Haemonetics Corporation (NYSE: HAE), a leading player in the medical devices sector, presents an intriguing investment opportunity for those interested in the healthcare industry. With a market capitalization of $2.39..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Unlocking a 21.49% Upside Potential for Investors

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands as a prominent player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a market capitalization of $1.07..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 36% Potential Upside in the Diagnostics & Research Sector

Investors keen on the healthcare sector’s diagnostics and research vertical will find Neogen Corporation (NASDAQ: NEOG) an intriguing prospect, especially given its potential upside of 36.18%. Based in Lansing, Michigan,..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A Closer Look at Its 19.51% Upside Potential

Investors looking to capitalize on growth within the healthcare sector should pay close attention to U.S. Physical Therapy, Inc. (NYSE: USPH). With a market cap of $1.36 billion, this Houston-based..

AtriCure, Inc. (ATRC) Stock Analysis: A Healthcare Innovator with a 43.97% Upside Potential

AtriCure, Inc. (NASDAQ: ATRC), a leader in the medical instruments and supplies industry, is capturing investor attention with a compelling narrative of growth potential and innovation in cardiac surgery solutions...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds